Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Becker
A Gilbert

Showing results (311-320 of 4,981) with videos related to

Pageof 499
Sort By:
Clinical Cardiology|April 1, 1994
Beta-adrenergic blockade following thrombolytic therapy: is it helpful or harmful?R C Becker
Cardiology|January 1, 1991
Seminars in thrombosis, thrombolysis and vascular biology. 3. Platelet activity in cardiovascular diseaseR C Becker
Journal of the American College of Cardiology|October 30, 2007
Emerging paradigms, platforms, and unifying themes in biomarker scienceRichard C Becker
Journal of Thrombosis and Thrombolysis|April 24, 2007
Emergence of factor IXa as a target for pharmacologic inhibition: editors pageRichard C Becker
Clinical Cardiology|March 31, 2004
Recent update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: role of antiplatelet therapyRichard C Becker
Journal of Thrombosis and Thrombolysis|March 25, 2005
Factor Xa-protease activated receptor interface: a paradigm for combination pharmacotherapyRichard C Becker
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1991
Radionuclide ventriculography: should Fourier analysis replace the cine display?L C Becker
Journal of Thrombosis and Thrombolysis|August 6, 2005
Patient-specific antithrombotic strategies: lessons not yet learned from the renal insufficiency paradigmRichard C Becker
The American Journal of Cardiology|January 3, 1992
Thrombin antagonists and antiplatelet agentsR C Becker
Journal of Thrombosis and Thrombolysis|February 6, 2007
Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug developmentRichard C Becker
Pageof 499

Showing results (311-320 of 4,981) with videos related to

Sort By:
Pageof 499
Clinical Cardiology|April 1, 1994
Beta-adrenergic blockade following thrombolytic therapy: is it helpful or harmful?R C Becker
Cardiology|January 1, 1991
Seminars in thrombosis, thrombolysis and vascular biology. 3. Platelet activity in cardiovascular diseaseR C Becker
Journal of the American College of Cardiology|October 30, 2007
Emerging paradigms, platforms, and unifying themes in biomarker scienceRichard C Becker
Journal of Thrombosis and Thrombolysis|April 24, 2007
Emergence of factor IXa as a target for pharmacologic inhibition: editors pageRichard C Becker
Clinical Cardiology|March 31, 2004
Recent update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: role of antiplatelet therapyRichard C Becker
Journal of Thrombosis and Thrombolysis|March 25, 2005
Factor Xa-protease activated receptor interface: a paradigm for combination pharmacotherapyRichard C Becker
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1991
Radionuclide ventriculography: should Fourier analysis replace the cine display?L C Becker
Journal of Thrombosis and Thrombolysis|August 6, 2005
Patient-specific antithrombotic strategies: lessons not yet learned from the renal insufficiency paradigmRichard C Becker
The American Journal of Cardiology|January 3, 1992
Thrombin antagonists and antiplatelet agentsR C Becker
Journal of Thrombosis and Thrombolysis|February 6, 2007
Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug developmentRichard C Becker
Pageof 499